Literature DB >> 15149726

Pro7.33(303) of the human GnRH receptor regulates selective binding of mammalian GnRH.

Bernhard J Fromme1, Arieh A Katz, Robert P Millar, Colleen A Flanagan.   

Abstract

Mammalian gonadotropin releasing hormone (GnRH) receptors have a conserved acidic residue (Glu7.32(301) or Asp7.32(302)) in extracellular loop (ECL) three that confers selectivity for mammalian GnRH, which has Arg8. Comparison of mammalian and non-mammalian GnRH receptors suggested that the acidic residue is not the only determinant of ligand selectivity in mammalian receptors. The acidic residue is followed by a conserved Pro7.33 in mammalian GnRH receptors, but not non-mammalian receptors. Unique structural constraints imposed by Pro residues suggested that Pro7.33 determines selective binding of Arg8-containing GnRH, by stabilising the conformation of the third extracellular loop of the receptor. Substituting Pro7.33(303) or introducing Pro to position 7.31 decreased affinity for GnRH, but not analogs lacking Arg8. Substituting Pro7.33(303) changed the predicted alpha-helix content of the loop-helix interface. These results show that Pro7.33(303) of the human GnRH receptor is required for selective high affinity binding of mammalian GnRH and supports the hypothesis that Pro7.33(303) stabilises a loop conformation that is necessary for selective ligand binding. Copyright 2004 Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15149726     DOI: 10.1016/j.mce.2004.01.009

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  1 in total

1.  R31C GNRH1 mutation and congenital hypogonadotropic hypogonadism.

Authors:  Luigi Maione; Frederique Albarel; Philippe Bouchard; Megan Gallant; Colleen A Flanagan; Regis Bobe; Joelle Cohen-Tannoudji; Rosario Pivonello; Annamaria Colao; Thierry Brue; Robert P Millar; Marc Lombes; Jacques Young; Anne Guiochon-Mantel; Jerome Bouligand
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.